RPS6KB1 and sarcoidosis: Even though no association between different clinical phenotypes and S6K activation could be found in sarcoidosis, the subdivision of sarcoidosis patients by S6K activation detected in the granuloma could possibly benefit the personalized medicine of this disease regarding choice of immunosuppressive therapy.